These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2967231)

  • 1. In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate.
    Grenman SE; Roberts JA; England BG; Grönroos M; Carey TE
    Gynecol Oncol; 1988 Jun; 30(2):239-50. PubMed ID: 2967231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
    Nomura Y; Tashiro H; Takaeko F
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinoma.
    Rendina GM; Donadio C; Fabri M; Mazzoni P; Nazzicone P
    Eur J Obstet Gynecol Reprod Biol; 1984 Jun; 17(4):285-91. PubMed ID: 6235140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay.
    Osborne CK; Von Hoff DD; Mullins K
    Breast Cancer Res Treat; 1985; 6(3):229-35. PubMed ID: 2936413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
    Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M
    Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of UM-EC-2, a tamoxifen-sensitive, estrogen receptor-negative human endometrial carcinoma cell line.
    Grenman SE; Worsham MJ; Van Dyke DL; England B; McClatchey KD; Babu VR; Roberts JA; Mäenpää J; Carey TE
    Gynecol Oncol; 1990 May; 37(2):188-99. PubMed ID: 2344964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.
    Noguchi S; Yamamoto H; Inaji H; Imaoka S; Koyama H
    Jpn J Cancer Res; 1989 Mar; 80(3):244-8. PubMed ID: 2524460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
    Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
    Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer.
    van Veelen H; Willemse PH; Tjabbes T; Schweitzer MJ; Sleijfer DT
    Cancer; 1986 Jul; 58(1):7-13. PubMed ID: 2939943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal therapy of human endometrial adenocarcinoma in a nude mouse model.
    Zaino RJ; Satyaswaroop PG; Mortel R
    Cancer Res; 1985 Feb; 45(2):539-41. PubMed ID: 3967228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid receptors and response of endometrial cancer to hormones in vitro.
    Grönroos M; Mäenpää J; Kangas L; Erkkola R; Paul R; Grenman S
    Ann Chir Gynaecol Suppl; 1987; 202():76-9. PubMed ID: 2959189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of aromatase activity in human endometrial stromal cells by steroids, tamoxifen and RU 486.
    Tseng L; Mazella J; Sun B
    Endocrinology; 1986 Apr; 118(4):1312-8. PubMed ID: 2936597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitro.
    Geisinger KR; Berens ME; Duckett Y; Morgan TM; Kute TE; Welander CE
    Cancer; 1990 Mar; 65(5):1055-61. PubMed ID: 2137365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of transforming growth factor gene expression in human endometrial adenocarcinoma cells.
    Murphy LJ; Gong Y; Murphy LC
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):309-14. PubMed ID: 1532902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.
    Byrne MJ; Gebski V; Forbes J; Tattersall MH; Simes RJ; Coates AS; Dewar J; Lunn M; Flower C; Gill PG; Stewart J
    J Clin Oncol; 1997 Sep; 15(9):3141-8. PubMed ID: 9294477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
    Iino Y; Ishikawa H; Izuo M; Takikawa H
    Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro response of cervical cancer cell lines CaSki, HeLa, and ME-180 to the antiestrogen tamoxifen.
    Grenman S; Shapira A; Carey TE
    Gynecol Oncol; 1988 Jun; 30(2):228-38. PubMed ID: 3371749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tamoxifen, medroxyprogesterone acetate and estradiol on tumor growth and oncogene expression in MCF-7 breast cancer cell line transplanted into nude mice.
    Mizukami Y; Tajiri K; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Nakamura S; Matsubara F
    Anticancer Res; 1991; 11(3):1333-8. PubMed ID: 1832273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of endocrine therapy on the proliferation of estrogen (ER) positive cells and ER negative cells of human breast cancer (MCF-7)].
    Noguchi M; Tajiri K; Taniya T; Kumaki T; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1989 May; 90(5):780-5. PubMed ID: 2529423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating sequential endocrine therapy: tamoxifen and medroxyprogesterone acetate versus tamoxifen in postmenopausal advanced breast cancer patients.
    Beltrán M; Alonso MC; Ojeda MB; Izquierdo A; Ferrer J; Picó C; Anglada L; Catalán G; Batiste-Alentorn E; Tusquets I
    Ann Oncol; 1991 Jul; 2(7):495-9. PubMed ID: 1832944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.